Prescient Therapeutics LimitedASX: PTX

First Patient dosed for PTX-100 Phase 2a Study

May 27, 2025 at 3:28 AM UTC · Issued by Prescient Therapeutics Limited

Prescient Therapeutics Ltd has released a press release.

View Attachment